Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Neogenomics Inc gives FY 2014 guidance in line with analysts' estimates; gives Q1 2014 guidance; revenue guidance above analysts' estimates


Wednesday, 19 Feb 2014 07:00am EST 

Neogenomics Inc:Expects revenue of $73-$77 mln and net income of $0.05-$0.07 per share in fiscal 2014.Expects revenue of $18.8-$19.3 mln and net income of $0.01-$0.02 per share (EPS) for first quarter of 2014.Fiscal 2014 revenue of $73 mln and EPS of $0.07 - Thomson Reuters I/B/E/S.First quarter 2014 revenue of $18.0 mln and EPS of $0.01 - Thomson Reuters I/B/E/S. 

Company Quote

3.88
0.3 +8.38%
23 Jan 2015